What Wiewelhove GmbH does

Wiewelhove GmbH is a privately held, owner-managed German pharmaceutical contract development and manufacturing organization (CDMO) specializing in solid dosage forms. Founded in 1976 in Ibbenbüren, Germany — tracing its origins to the 1957 Stern pharmacy — the company operates multiple production and laboratory buildings on a single campus and offers end-to-end services spanning galenic development, formulation, process validation, and commercial supply. Its customer base consists of domestic and international pharmaceutical companies, and the company positions itself as a flexible mid-sized alternative to large CDMOs while claiming the capability to serve "the world's largest pharmaceutical companies."

The company's core technology stack is built on conventional solid-dose manufacturing processes: wet granulation (including fluid bed granulation), compaction, blending, tabletting, capsule filling, film and sugar coating, bottling, and blister packaging. These are supported by in-house galenic development laboratories, quality control and stability testing facilities, and project management and validation services. Recent capital investments include a second fluidized bed granulation plant (commissioned 2026), a new Uhlmann BEC 300 packaging line that expanded packaging capacity by approximately 25% and enabled PP mono-material blister production, and a new container filling system. The company holds GMP certifications across all four production sites, EN ISO 13485:2016/A11:2021, IFS Food, Halal certification (2026-2027), and a German manufacturing permit.

Wiewelhove operates a B2B services revenue model. Revenue is generated through project-based and long-term supply agreements typical of pharmaceutical CDMOs, with pricing negotiated per project via a direct sales team led by a Head of Sales, five Sales Managers, and a Sales & Business Development lead. With approximately 300 employees, the company describes itself as one of the smaller German pharmaceutical manufacturers. Marketing channels are limited to direct sales consultation, CPhI Frankfurt trade fair participation, and a modest organic social media and employer branding presence. Sustainability positioning (PP mono-material blisters, recyclable packaging) is an emerging commercial theme.

Name

Wiewelhove GmbH

Legal name

Wiewelhove GmbH

Website

https://wiewelhove.de

Company type

Private

Founded year

1976

Operating status

Operating

Short description

Wiewelhove GmbH is a German, family-owned pharmaceutical contract manufacturer (CDMO) specializing in solid dosage forms — tablets and capsules — serving European and international pharma companies with GMP-certified production, galenic development, and packaging services from its Ibbenbüren campus.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254)

akta.pro primary industry

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)

akta.pro secondary industry

Packaging, Labeling & Serialization (Clinical/Commercial) CDMO (HLAGABAJ)

Keywords

• Pharmaceutical contract manufacturing
• Solid dosage forms
• Galenic development
• Pharmaceutical CDMO
• Tablet manufacturing

Headquarters

HQ city

Ibbenbüren

HQ country

Germany

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D

Revenue model

1. Contract Manufacturing Services: Wiewelhove provides contract manufacturing services for solid dosage forms to pharmaceutical companies. Services include wet granulation, compaction, blending, tabletting, capsule filling, film coating, sugar coating, bottling, blistering and packaging, along with galenic development, project management, and validation services. Revenue is generated through service fees for manufacturing and development projects, likely structured as project-based or long-term supply agreements typical of pharmaceutical CDMOs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Wiewelhove GmbH is a contract manufacturing organization (CDMO) for solid dosage forms serving the pharmaceutical industry. Its core offering covers the full manufacturing chain for solid oral dosage forms, including wet granulation, compaction, blending, tabletting, capsule filling, film and sugar coating, and primary packaging (bottling and blistering). The company also provides galenic development, project management, validation, and quality control / stability analyses as integrated services alongside its manufacturing work.

Product overview

Wiewelhove GmbH is a contract manufacturing organization (CMO) specializing in solid dosage forms for the pharmaceutical industry. The company operates as a single integrated platform offering manufacturing services and supporting services. The core manufacturing portfolio includes wet granulation, compaction, blending, tabletting, capsule filling, film coating, sugar coating, bottling, and blister packaging. These manufacturing services are supported by Galenic Development (formulation development), Quality Control, Stability Analyses, Project Management, and Validation services. The company operates multiple production facilities at its Ibbenbüren, Germany site, including dedicated areas for fluid bed granulation, tabletting, coating, and packaging. In 2026, Wiewelhove celebrated its 50th anniversary and continues to expand capacity through investments like the new Uhlmann BEC 300 packaging line.

Differentiator

Problem solved

Functional benefit

Products and services

• Contract Manufacturing of Solid Dosage Forms End-to-end contract manufacturing of solid oral dosage forms for pharmaceutical companies, including wet granulation, compaction, blending, tabletting, capsule filling, film coating, sugar coating, and primary packaging (bottling and blistering). Delivered under GMP-certified conditions at multi-site production facilities in Ibbenbüren, Germany.
• Galenic Development Services Formulation and galenic development services for solid dosage forms, supporting pharmaceutical clients from early formulation through manufacturing-ready processes as a precursor to commercial production.
• Project Management and Validation Services Dedicated project management and process / cleaning validation services to support pharmaceutical client manufacturing campaigns, ensuring regulatory-compliant execution of CDMO projects.
• Quality Control and Stability Analysis Services Pharmaceutical quality control testing and stability analyses for solid dosage forms, supporting batch release and ongoing stability programs to GMP standards.

Quantifiable outcome

• 25% increase in packaging capacity
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators4 records

Recent moves19 records

Expansion highlights10 records

Direct peers

• Aenova Group: German-headquartered CDMO with a strong solid dosage form offering (tablets, capsules, softgels) across multiple European sites. Aenova is a directly comparable European solid-dose contract manufacturer serving similar big-pharma customers.
• Temmler Pharma GmbH & Co. KG: German pharmaceutical contract developer and manufacturer offering solid dosage forms and related services. A domestic peer with overlapping capabilities in galenic development and contract manufacturing.
• Rottendorf Pharma GmbH: Mid-sized German family-owned CDMO focused on solid dosage forms (tablets, capsules) with galenic development and packaging services. Closely comparable in size, ownership profile, and service scope to Wiewelhove.

Broad incumbents

• Eurofins CDMO: Global contract development and manufacturing network offering pharmaceutical services including solid dosage forms. Comparable as a CDMO serving pharma customers, with broader testing and manufacturing capabilities.
• Recipharm AB: Swedish-headquartered, large-scale European CDMO with broad service offerings across solid, semi-solid, and other dosage forms. Comparable as a contract manufacturer serving big pharma, but at significantly larger scale than Wiewelhove.
• NextPharma Technologies Holding GmbH: European CDMO offering contract development and manufacturing across solid, semi-solid, and other dosage forms. Overlaps with Wiewelhove in solid-dose contract manufacturing for pharmaceutical customers.
• Siegfried Holding AG: Swiss-listed CDMO with API and drug product manufacturing including solid dosage forms. A larger, publicly listed European peer with overlapping solid-dose capabilities and a similar focus on contract manufacturing for big pharma.
• Hovione S.A. Portuguese-headquartered CDMO with drug substance and drug product services including solid dosage forms. A comparable European-based contract manufacturer with broader capabilities and an established pharma customer base.
• Catalent, Inc. Global CDMO with extensive solid-dose, sterile, and biologics capabilities across many geographies. Represents the scale ceiling that Wiewelhove competes against for tier-1 sponsor contracts.

Others

• Uhlmann Pac-Systeme GmbH & Co. KG: German provider of pharmaceutical packaging machinery and integrated packaging lines, including the BEC 300 blister line Wiewelhove recently installed. While not a CDMO, Uhlmann is an equipment/enabling partner adjacent to Wiewelhove's packaging operations.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/wiewelhove-gmbh
• Instagraminstagram.com/wiewelhovegmbh

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wiewelhove GmbH